Cardiagutt en es it fr

Cardiagutt Brand names, Cardiagutt Analogs

Cardiagutt Brand Names Mixture

  • Tarka (trandolapril + verapamil hydrochloride)

Cardiagutt Chemical_Formula

C27H38N2O4

Cardiagutt RX_link

http://www.rxlist.com/cgi/generic/verapsr.htm

Cardiagutt fda sheet

Cardiagutt FDA

Cardiagutt msds (material safety sheet)

Cardiagutt Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Cardiagutt Molecular Weight

454.602 g/mol

Cardiagutt Melting Point

< 25 oC

Cardiagutt H2O Solubility

4.47 mg/L

Cardiagutt State

Liquid

Cardiagutt LogP

5.931

Cardiagutt Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Cardiagutt Indication

For the treatment of hypertension and angina.

Cardiagutt Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Cardiagutt Absorption

90%

Cardiagutt side effects and Toxicity

LD50=8 mg/kg (i.v. in mice)

Cardiagutt Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Cardiagutt Organisms Affected

Humans and other mammals